$1.32 -0.03 (-2.27%)

Fractyl Health, Inc. Common Stock (GUTS)

Fractyl Health, Inc. is a clinical-stage biotech company focused on developing transformative treatments for metabolic and gastrointestinal diseases. Known for its innovative approach to advancing therapies targeting conditions like type 2 diabetes and other metabolic disorders, the company emphasizes minimally invasive procedures and novel technologies to improve patient outcomes.

🚫 Fractyl Health, Inc. Common Stock does not pay dividends

Company News

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
GlobeNewswire Inc. • Fractyl Health • September 26, 2025

Fractyl Health reported promising clinical trial results showing their Revita procedure maintained weight loss after patients stopped GLP-1 drugs, with treated patients losing 2.5% body weight compared to a 10% weight regain in the control group.

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • April 3, 2024

Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro. Cal-Maine Foods shares jumped 8...

EDBLIVPCISSCALMINTCHWH
Wall Street hungry for IPO of Mexican supermarket chain BBB Foods as stock rises 9%
MarketWatch • MarketWatch • February 9, 2024

BBB Foods’ stock rises in its first day of trading as IPO market churns out deals.

TBBBKYTXPMNTANRO